Cell Therapy in Ophthalmological Disease
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Regenerative Engineering".
Deadline for manuscript submissions: closed (10 March 2025) | Viewed by 1006
Special Issue Editor
Interests: tissue engineering; cells; bioremediation; stem cells; regenerative therapies
Special Issue Information
Dear Colleagues,
The field of ophthalmological cell therapy is rapidly advancing, offering promising avenues for treating various ocular diseases. This Special Issue explores cutting-edge research and innovations aimed at regenerating ocular defects, assessing treatment efficacy through novel in vitro models, and introducing new cell therapies. Recent developments highlight exciting new approaches for regenerating ocular defects. Stem cell-based therapies show potential in repairing damaged retinal tissue and restoring visual function. Advances in gene editing techniques, such as CRISPR-Cas9, offer precise tools for correcting genetic mutations implicated in inherited eye disorders like retinitis pigmentosa or ocular pemphigus. In vitro models have evolved significantly, providing more accurate platforms to evaluate the efficacy and safety of cell therapies. Organoid cultures derived from patient-specific cells allow researchers to mimic complex ocular tissues, facilitating personalized treatment strategies. Moreover, novel cell therapies are emerging as promising treatments for a spectrum of ocular diseases. From retinal pigment epithelial cell transplants for age-related macular degeneration to mesenchymal stem cell injections for diabetic retinopathy, these therapies aim to halt disease progression and improve visual outcomes. This Special Issue consolidates the latest research advancements, offering insights into the future landscape of ophthalmological cell therapy. By highlighting innovative approaches and transformative therapies, it seeks to catalyze further progress in the field, ultimately enhancing the quality of life for patients with ocular diseases.
Prof. Dr. Florian K. Groeber-Becker
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ophthalmological cell therapy
- retinal pigment epithelial cell transplants
- mesenchymal stem cell
- ocular disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
